This week's big news is that an AI tested thousands of drug combinations and found a 7-drug mix that could keep lung strength at 98.3% — a result that gives real hope for people living with IPF (scarring of the lungs).
FVC = how much air your lungs can push out. Higher % = healthier lungs. A typical IPF patient starts around 50–60%.
This is a computer model result — not a prescription. Always talk to your doctor before changing anything.
This week our database grew to over 5,300 IPF studies and 1,490 clinical trials (real-world tests on patients). Most new papers came from Russia and from early-stage research postings, meaning scientists worldwide are actively hunting for answers. One paper looked at how a protein called HIF-1α affects cell self-cleaning and iron-related cell death — processes that may play a role in lung scarring. Another explored lung nodule (small spot) screening using low-dose CT scans paired with AI, which could help catch lung problems earlier.
The AI this week tested drug combinations and its best result kept FVC (a measure of how much air your lungs can push out — basically a score for lung strength) at 98.3%. That is almost normal! The winning mix included 7 drugs that target different parts of the scarring process, from calming overactive cells to helping the lungs repair themselves.
One question to ask your lung doctor at your next visit: "Are any of the new drugs targeting lung cell repair, like inhaled FGF10 or ROCK inhibitors, being tested in clinical trials I might qualify for?"